SEC Form 4 · accession 0001609351-19-000004
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Perez
Director
Period of report
Jan 3, 2019
Accepted (ET)
Jan 4, 2019 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2019 | M | 1,000 | — | A | 1,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 3, 2019 | M | 1,000 | D | — | — | Common Stock | 1,000 | 2,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- F2On January 3, 2018, the reporting person was granted 3,000 restricted stock units that vest in three equal annual installments beginning January 3, 2019. Vested shares will be delivered to the reporting person annually on the vesting date.